Perineuronal nets (PNNs) are specialized aggregations of extracellular matrix (ECM) molecules surrounding specific neurons in the central nervous system (CNS). PNNs are supposed to control synaptic transmission and are frequently associated with neurons firing at high rates, including principal neurons of auditory brainstem nuclei. The origin of high-frequency activity of auditory brainstem neurons is the indefatigable sound-driven transmitter release of inner hair cells (IHCs) in the cochlea.
Pubmed ID: 30253762 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A national mouse monoclonal antibody generating resource for biochemical and immunohistochemical applications in mammalian brain. NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the initial NeuroMab screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e. NeuroMabs): for immunocytochemical-based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks. The NeuroMab facility was initially funded with a five-year U24 cooperative grant from NINDS and NIMH. The initial goal of the facility for this funding period is to generate a library of novel NeuroMabs against neuronal proteins, initially focusing on membrane proteins (receptors/channels/transporters), synaptic proteins, other neuronal signaling molecules, and proteins with established links to disease states. The scope of the facility was expanded with supplements from the NIH Blueprint for Neuroscience Research to include neurodevelopmental targets, the NIH Roadmap for Medical Research to include epigenetics targets, and NIH Office of Rare Diseases Research to include rare disease targets. These NeuroMabs will then be produced on a large scale and made available to the neuroscience research community on an inexpensive basis as tissue culture supernatants or purified immunoglobulin by Antibodies Inc. The UC Davis/NIH NeuroMab Facility makes NeuroMabs available directly to end users and is unable to accommodate sales to distributors for third party distribution. Note, NeuroMab antibodies are now offered through antibodiesinc.
View all literature mentionsCommercial vendor and service provider of laboratory reagents and antibodies. Supplier of scientific instrumentation, reagents and consumables, and software services.
View all literature mentionsSoftware for image processing, analysis, and editing. The software includes features such as touch capabilities, a customizable toolbar, 2D and 3D image merging, and Cloud access and options.
View all literature mentionsAmerican chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.
View all literature mentionsA commercial antibody supplier which supplies primary and secondary antibodies, biochemicals, proteins, peptides, lysates, immunoassays and other kits.
View all literature mentionslaboratory mouse with name C57BL/6N from MGI.
View all literature mentionsThis monoclonal targets Brevican
View all literature mentionsThis polyclonal targets Human HAPLN1
View all literature mentionsThis polyclonal targets Aggrecan, amino acids 1177-1326
View all literature mentionsThis polyclonal targets Human HAPLN4 Affinity Purified Ab
View all literature mentionsThis polyclonal targets Neurocan
View all literature mentionsThis polyclonal targets VGLUT 3
View all literature mentionsThis monoclonal targets PSD-95 MAGUK scaffold protein
View all literature mentionsThis unknown targets CaV1.3 (CACNA1D) Channel
View all literature mentionsThis monoclonal targets AMPA Receptor (GluR 4) (D41A11) XP Rabbit mAb
View all literature mentionsThis polyclonal targets Metabotropic Glutamate Receptor 2/3
View all literature mentionsThis monoclonal targets Myelin Basic Protein
View all literature mentionsThis monoclonal targets CtBP2
View all literature mentionsThis monoclonal targets Tenascin-R
View all literature mentionsThis polyclonal targets Human HAPLN1
View all literature mentionsThis polyclonal targets Aggrecan, amino acids 1177-1326
View all literature mentionsThis polyclonal targets Aggrecan, amino acids 1177-1326
View all literature mentionsThis monoclonal targets Brevican
View all literature mentionsThis polyclonal targets Neurocan
View all literature mentionsThis polyclonal targets Human HAPLN4 Affinity Purified Ab
View all literature mentionsThis polyclonal targets Aggrecan, amino acids 1177-1326
View all literature mentionsThis polyclonal targets Human HAPLN1
View all literature mentionsThis polyclonal targets VGLUT 3
View all literature mentionsThis monoclonal targets PSD-95 MAGUK scaffold protein
View all literature mentionsThis unknown targets CaV1.3 (CACNA1D) Channel
View all literature mentionsThis monoclonal targets AMPA Receptor (GluR 4) (D41A11) XP Rabbit mAb
View all literature mentionsThis polyclonal targets Metabotropic Glutamate Receptor 2/3
View all literature mentionsThis monoclonal targets Myelin Basic Protein
View all literature mentionsThis monoclonal targets CtBP2
View all literature mentionsThis monoclonal targets Tenascin-R
View all literature mentionsThis polyclonal targets Human HAPLN4 Affinity Purified Ab
View all literature mentionsThis polyclonal targets Human HAPLN1
View all literature mentionsThis polyclonal targets Neurocan
View all literature mentionsThis polyclonal targets Aggrecan, amino acids 1177-1326
View all literature mentionsThis monoclonal targets Brevican
View all literature mentions